broker29 Mar 2010 12:37
1009 GMT [Dow Jones] KBC Peel Hunt cuts Antisoma (ASM.LN) target to 33p from 70p as it takes the company's flagsip cancer medicine, ASA404, out of its valuation. This comes after Antisoma says a trial for the drug will be stopped after data show it wasn't going to work